TriClip G4:对于三管吐治疗的游戏改变者
Eman Mahboob1, Muhammad Ammar Samad1, Caleb Carver2
1Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Current problems in cardiology
|May 31, 2024
概括
在高风险患者中,TriClip G4系统为严重的三门吐 (TR) 提供了一种新的干预治疗方法. 临床试验显示有希望的结果,成本效益和改善生活质量.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 三管回 (TR) 带来了重大管理挑战.
- 现有的治疗方法包括EVOQUE,皮结婚整形和手术修复.
- TriClip G4系统是一种用于TR治疗的新型跨导管装置.
研究的目的:
- 审查TriClip G4系统的程序方面,学习曲线和结果.
- 为了将TriClip G4系统与TR的其他干预疗法进行比较.
- 评估TriClip G4对症状严重的TR的疗效和安全性.
主要方法:
- 对TriClip G4系统的关键临床试验和现有文献的审查.
- 分析程序技术和相关的学习曲线.
- 对替代TR干预措施进行比较评估.
主要成果:
- 在临床试验中,TriClip G4系统已经显示出有前途的结果.
- 该设备与成本效益和改善患者生活质量有关.
- 在TriClip G4系统显示了与传统方法相比独特的优势.
结论:
- TriClip G4系统是FDA批准的选择,用于中等或更高的外科风险的症状严重的TR患者.
- 这种设备扩大了TR的干预治疗选择.
- TriClip G4系统为现有的TR治疗提供了一个潜在的有价值的替代方案.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


